Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants

International Journal of Obesity

Volumn 34, Issue 10, 2010, Pages 1546-1553

  Ollholm J ^a,b   Paulsen, S K ^a,b   Cullberg, K B ^a,b   Richelsen, B ^a,b   Pedersen, S B ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

adipokine; adipose tissue; inflammation; resveratrol; sirtuins

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FULVESTRANT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESVERATROL; SIRTINOL;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; EXPLANT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN SECRETION;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; MALE; OBESITY; RNA, MESSENGER; STILBENES;

RICE STRIPE VIRUS; RODENTIA;

EID: 77957923658     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.98     Document Type: Article

References (42)

1. Ingram DK, Zhu M, Mamczarz J, Zou S, Lane MA, Roth GS et al. Calorie restriction mimetics: an emerging research field. Aging Cell 2006; 5: 97-108.
2. Ingram DK, Anson RM, de Cabo R, Mamczarz J, Zhu M, Mattison J et al. Development of calorie restriction mimetics as a prolonge-vity strategy. Ann NYAcad Sci 2004; 1019: 412-423.
3. Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 2005; 6: 298-305.
4. McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 1989; 5: 155-171.
5. Heilbronn LK, Ravussin E. Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr 2003; 78: 361-369.
6. Walford RL, Mock D, Verdery R, MacCallum T. Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormo-nal, and biochemical parameters in humans restricted for a 2-year period. J Gerontol A Biol Sci Med Sci 2002; 57: B211-B224.
7. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000; 289: 2126-2128.
8. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, hado de Oliveira R et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-[gamma]. Nature 2004; 429: 771-776.
9. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425: 191-196.
10. Pedersen SB, Olholm J, Paulsen SK, Bennetzen MF, Richelsen B. Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women. Int J Obes 2008; 32: 1250-1255.
11. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337-342.
12. Deng JY, Hsieh PS, Huang JP, Lu LS, Hung LM. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and-independent pathways. Diabetes 2008; 57: 1814-1823.
13. Gonzales A, Orlando R. Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab 2008; 5: 17.
14. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
15. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-Reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
16. Tilg H, Moschen AR Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nat Rev Immunol 2006; 6: 772-783.
17. Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B. Associa-tion between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 2003; 148: 535-542.
18. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
19. Feve B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2009; 5: 305-311.
20. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumula-tion in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
21. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33 (Part 5): 1078-1081.
22. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulangé A, Capeau Jet al. Long-term treatment with interleukin-1ß induces insulin resistance in murine and human adipocytes. Diabetologia 2006; 49/9: 2162-2173.
23. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004; 219: 9-15.
24. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
25. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13: 84-89.
26. Trujillo ME, Scherer PE. Adiponectin\journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005; 257: 167-175.
27. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946.
28. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792.
29. Flower L, Gray R, Pinkney J, Mohamed-Ali V. Stimulation of interleukin-6 release by interleukin-1[beta] from isolated human adipocytes. Cytokine 2003; 21: 32-37.
30. Zeyda M, Stulnig TM. Adipose tissue macrophages. Immunol Lett 2007; 112: 61-67.
31. Dahlman I, Kaaman M, Olsson T, Tan GD, Bickerton AST, Wahlen K et al. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 2005; 90: 5834-5840.
32. Ahn J, Lee H, Kim S, Ha T. Resveratrol inhibits TNF-[alpha]-induced changes of adipokines in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2007; 364: 972-977.
33. Zhu J, Yong W, Wu X, Yu Y, Lv J, Liu C et al. Anti-inflammatory effect of resveratrol on TNF-[alpha]-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun 2008; 369: 471-477.
34. Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaisse JM. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 2005; 65: 9943-9952.
35. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
36. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007; 450: 712-716.
37. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380.
38. Pedersen SB, Fuglsig S, Sjogren P, Richelsen B. Identification of steroid receptors in human adipose tissue. Eur J Clin Invest 1996; 26: 1051-1056.
39. Bruun JM, Pedersen SB, Richelsen B. Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 2001; 86: 1267-1273.
40. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006; 26: 871-876.
41. Wang LX, Heredia A, Song H, Zhang Z, Yu B, Davis C et al. Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity. JPharm Sci 2004; 93: 2448-2457.
42. Park HJ, Yang JY, Ambati S, Della-Fera MA, Hausman DB, Rayalam S et al. Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J Med Food 2008; 11: 773-783.